Search

Your search keyword '"Lanzillo, Roberta"' showing total 1,068 results
Start Over Author "Lanzillo, Roberta"
1,068 results on '"Lanzillo, Roberta"'

1. Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod

Author

Carotenuto, Antonio, Di Monaco, Cristina, Papetti, Laura, Borriello, Giovanna, Signoriello, Elisabetta, Masciulli, Camilla, Tomassini, Valentina, De Luca, Giovanna, Ianniello, Antonio, Lus, Giacomo, Novarella, Federica, Spiezia, Antonio Luca, Di Somma, Dario, Moccia, Marcello, Petracca, Maria, Iacovazzo, Carmine, Servillo, Giuseppe, Portaccio, Emilio, Triassi, Maria, Amato, Maria Pia, Pozzilli, Carlo, Valeriani, Massimiliano, Brescia Morra, Vincenzo, and Lanzillo, Roberta

Published
2024
Full Text
View/download PDF

6. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis

Author

Maida, Elisabetta, Moccia, Marcello, Palladino, Raffaele, Borriello, Giovanna, Affinito, Giuseppina, Clerico, Marinella, Repice, Anna Maria, Di Sapio, Alessia, Iodice, Rosa, Spiezia, Antonio Luca, Sparaco, Maddalena, Miele, Giuseppina, Bile, Floriana, Scandurra, Cristiano, Ferraro, Diana, Stromillo, Maria Laura, Docimo, Renato, De Martino, Antonio, Mancinelli, Luca, Abbadessa, Gianmarco, Smolik, Krzysztof, Lorusso, Lorenzo, Leone, Maurizio, Leveraro, Elisa, Lauro, Francesca, Trojsi, Francesca, Streito, Lidia Mislin, Gabriele, Francesca, Marinelli, Fabiana, Ianniello, Antonio, De Santis, Federica, Foschi, Matteo, De Stefano, Nicola, Morra, Vincenzo Brescia, Bisecco, Alvino, Coghe, Giancarlo, Cocco, Eleonora, Romoli, Michele, Corea, Francesco, Leocani, Letizia, Frau, Jessica, Sacco, Simona, Inglese, Matilde, Carotenuto, Antonio, Lanzillo, Roberta, Padovani, Alessandro, Triassi, Maria, Bonavita, Simona, and Lavorgna, Luigi

Published
2024
Full Text
View/download PDF

7. Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunity

Author

Lepore, Maria Teresa, Bruzzaniti, Sara, La Rocca, Claudia, Fusco, Clorinda, Carbone, Fortunata, Mottola, Maria, Zuccarelli, Bruno, Lanzillo, Roberta, Brescia Morra, Vincenzo, Maniscalco, Giorgia Teresa, De Simone, Salvatore, Procaccini, Claudio, Porcellini, Antonio, De Rosa, Veronica, Galgani, Mario, Cassano, Silvana, and Matarese, Giuseppe

Published
2024
Full Text
View/download PDF

8. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

Author

Di Filippo, Massimiliano, Ferraro, Diana, Ragonese, Paolo, Prosperini, Luca, Maniscalco, Giorgia Teresa, Gallo, Antonio, Cavalla, Paola, Lorefice, Lorena, Nociti, Viviana, Di Sabatino, Elena, Clerico, Marinella, Guaschino, Clara, Radaelli, Marta, Fantozzi, Roberta, Buttari, Fabio, Laroni, Alice, Gajofatto, Alberto, Calabrese, Massimiliano, Malucchi, Simona, Paolicelli, Damiano, De Luca, Giovanna, Tomassini, Valentina, Lanzillo, Roberta, Moccia, Marcello, Solaro, Claudio, Cocco, Eleonora, Gasperini, Claudio, and Tortorella, Carla

Published
2024
Full Text
View/download PDF

9. Signs and symptoms of COVID‐19 in patients with multiple sclerosis

Author

Schiavetti, Irene, Carmisciano, Luca, Ponzano, Marta, Cordioli, Cinzia, Cocco, Eleonora, Marfia, Girolama Alessandra, Inglese, Matilde, Filippi, Massimo, Radaelli, Marta, Bergamaschi, Roberto, Immovilli, Paolo, Capobianco, Marco, De Rossi, Nicola, Brichetto, Giampaolo, Scandellari, Cinzia, Cavalla, Paola, Pesci, Ilaria, Confalonieri, Paolo, Perini, Paola, Trojano, Maria, Lanzillo, Roberta, Tedeschi, Gioacchino, Comi, Giancarlo, Battaglia, Mario Alberto, Patti, Francesco, Salvetti, Marco, Sormani, Maria Pia, Group, MuSC‐19 Study, Abbadessa, Gianmarco, Aguglia, Umberto, Allegorico, Lia, Allegri, Beatrice Maria Rossi, Alteno, Anastasia, Amato, Maria Pia, Annovazzi, Pietro, Antozzi, Carlo, Appendino, Lucia, Arena, Sebastiano, Baione, Viola, Balgera, Roberto, Barcella, Valeria, Baroncini, Damiano, Barrilà, Caterina, Bellacosa, Alessandra, Bellucci, Gianmarco, Bergamaschi, Valeria, Bezzini, Daiana, Biolzi, Beatrice, Bisecco, Alvino, Bonavita, Simona, Borriello, Giovanna, Bosa, Chiara, Bosco, Antonio, Bovis, Francesca, Bozzali, Marco, Brambilla, Laura, Morra, Vincenzo Brescia, Buccafusca, Maria, Bucciantini, Elisabetta, Bucello, Sebastiano, Buscarinu, Maria Chiara, Cabboi, Maria Paola, Calabrese, Massimiliano, Calabria, Francesca, Caleri, Francesca, Camilli, Federico, Caniatti, Luisa Maria, Cantello, Roberto, Capra, Ruggero, Capuano, Rocco, Carta, Patrizia, Celani, Maria Grazia, Cellerino, Maria, Cerqua, Raffaella, Chisari, Clara, Clerici, Raffaella, Clerico, Marinella, Cola, Gaia, Conte, Antonella, Conti, Marta Zaffira, Cordano, Christian, Cordera, Susanna, Corea, Francesco, Correale, Claudio, Cottone, Salvatore, Crescenzo, Francesco, Curti, Erica, d’Ambrosio, Alessandro, D’Amico, Emanuele, Danni, Maura Chiara, d’Arma, Alessia, Dattola, Vincenzo, de Biase, Stefano, De Luca, Giovanna, De Mercanti, Stefania Federica, De Mitri, Paolo, De Stefano, Nicola, Della Cava, Fabio Maria, Della Cava, Marco, and Di Lemme, Sonia

Subjects
Neurosciences, Multiple Sclerosis, Brain Disorders, Pain Research, Neurodegenerative, Good Health and Well Being, Humans, Aged, COVID-19, Ageusia, SARS-CoV-2, Anosmia, MuSC-19 Study Group, demyelinating diseases, disease-modifying treatment, multiple sclerosis, neurological disorders, Clinical Sciences, Neurology & Neurosurgery
Abstract

Background and purposeClinical outcomes of multiple sclerosis (MS) patients affected by coronavirus disease 2019 (COVID-19) have been thoroughly investigated, but a further analysis on main signs and symptoms and their risk factors still needs attention. The objective of this study was to group together and describe based on similarity the most common signs and symptoms of COVID-19 in MS patients and identify all factors associated with their manifestation.MethodLogistic and linear regression models were run to recognize factors associated with each pooled group of symptoms and their total number.ResultsFrom March 2020 to November 2021, data were collected from 1354 MS patients with confirmed infection of COVID-19. Ageusia and anosmia was less frequent in older people (odds ratio [OR] 0.98; p = 0.005) and more in smoker patients (OR 1.39; p = 0.049). Smoke was also associated with an incremental number of symptoms (OR 1.24; p = 0.031), substance abuse (drugs or alcohol), conjunctivitis and rash (OR 5.20; p = 0.042) and the presence of at least one comorbidity with shortness of breath, tachycardia or chest pain (OR 1.24; p = 0.008). Some disease-modifying therapies were associated with greater frequencies of certain COVID-19 symptoms (association between anti-CD20 therapies and increment in the number of concomitant symptoms: OR 1.29; p = 0.05). Differences in frequencies between the three waves were found for flu-like symptoms (G1, p = 0.024), joint or muscle pain (G2, p = 0.013) and ageusia and anosmia (G5, p

Published
2022

13. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)

Author

Chisari, Clara G., Bianco, Assunta, Brescia Morra, Vincenzo, Calabrese, Massimiliano, Capone, Fioravante, Cavalla, Paola, Chiavazza, Carlotta, Comi, Cristoforo, Danni, Maura, Filippi, Massimo, Iaffaldano, Pietro, Lanzillo, Roberta, Lo Fermo, Salvatore, Lucisano, Alessandra, Lugaresi, Alessandra, Lus, Giacomo, Marfia, Gerolama Alessandra, Marinelli, Fabiana, Mirabella, Massimiliano, Moiola, Lucia, Perin, Chiara, Realmuto, Sabrina, Toscano, Simona, Trojano, Maria, Vecchio, Domizia, and Patti, Francesco

Published
2023
Full Text
View/download PDF

19. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey

Author

Altieri, Manuela, Capuano, Rocco, Bisecco, Alvino, d'Ambrosio, Alessandro, Risi, Mario, Cavalla, Paola, Vercellino, Marco, Annovazzi, Pietro, Zaffaroni, Mauro, De Stefano, Nicola, Stromillo, Maria Laura, D'Amico, Emanuele, Zanghì, Aurora, Buscarinu, Maria Chiara, Lanzillo, Roberta, De Luca, Giovanna, Calabrese, Massimiliano, Lorefice, Lorena, Di Filippo, Massimiliano, Valentino, Paola, Gajofatto, Alberto, Marfia, Girolama Alessandra, Fuiani, Aurora, Nociti, Viviana, Tedeschi, Gioacchino, and Gallo, Antonio

Published
2023
Full Text
View/download PDF

24. Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis

Author

Abbadessa, Gianmarco, Ponzano, Marta, Bile, Floriana, Miele, Giuseppina, Signori, Alessio, Cepparulo, Simone, Sparaco, Maddalena, Signoriello, Elisabetta, Maniscalco, Giorgia Teresa, Lanzillo, Roberta, Morra, Vincenzo Brescia, Lus, Giacomo, Sormani, Maria Pia, Lavorgna, Luigi, and Bonavita, Simona

Published
2023
Full Text
View/download PDF

26. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

Author

Baroncini, Damiano, Ghezzi, Angelo, Guaschino, Clara, Moiola, Lucia, Filippi, Massimo, Ianniello, Antonio, Pozzilli, Carlo, Lanzillo, Roberta, Brescia-Morra, Vincenzo, Margoni, Monica, Gallo, Paolo, Callari, Graziella, Grimaldi, Luigi, Lus, Giacomo, Calabrese, Massimiliano, Simone, Marta, Marfia, Girolama Alessandra, Rasia, Sarah, Cargnelutti, Daniela, Comi, Giancarlo, and Zaffaroni, Mauro

Published
2022
Full Text
View/download PDF

27. Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis

Author

Greco, Giacomo, primary, Risi, Mario, additional, Masciocchi, Stefano, additional, Businaro, Pietro, additional, Rigoni, Eleonora, additional, Zardini, Elisabetta, additional, Scaranzin, Silvia, additional, Morandi, Chiara, additional, Diamanti, Luca, additional, Foiadelli, Thomas, additional, Giannoccaro, Maria Pia, additional, Morelli, Luana, additional, Liguori, Rocco, additional, Barone, Paolo, additional, Tozzo, Alessandra, additional, Passarini, Alice, additional, Gelibter, Stefano, additional, Patti, Francesco, additional, Banfi, Paola, additional, Simone, Anna Maria, additional, Bisecco, Alvino, additional, Ruggieri, Martino, additional, Maimone, Davide, additional, Bruno, Giorgia, additional, Siliquini, Sabrina, additional, Bova, Stefania, additional, Di Filippo, Massimiliano, additional, Lanzillo, Roberta, additional, Gallo, Antonio, additional, Colombo, Elena, additional, Franciotta, Diego, additional, and Gastaldi, Matteo, additional

Published
2024
Full Text
View/download PDF

30. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

Author

Buonomo, Antonio Riccardo, Viceconte, Giulio, Calabrese, Massimiliano, De Luca, Giovanna, Tomassini, Valentina, Cavalla, Paola, Maniscalco, Giorgia Teresa, Ferraro, Diana, Nociti, Viviana, Radaelli, Marta, Buscarinu, Maria Chiara, Paolicelli, Damiano, Gajofatto, Alberto, Annovazzi, Pietro, Pinardi, Federica, Di Filippo, Massimiliano, Cordioli, Cinzia, Zappulo, Emanuela, Scotto, Riccardo, Gentile, Ivan, Spiezia, Antonio Luca, Petruzzo, Martina, De Angelis, Marcello, Brescia Morra, Vincenzo, Solaro, Claudio, Gasperini, Claudio, Cocco, Eleonora, Moccia, Marcello, and Lanzillo, Roberta

Published
2022
Full Text
View/download PDF

33. Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden.

Author

Ranucci, Davide, Falco, Fabrizia, Nicolella, Valerio, Di Monaco, Cristina, Migliaccio, Laura, Lamagna, Federica, Caracciolo, Federica, Eliano, Martina, Petracca, Maria, Moccia, Marcello, Brescia Morra, Vincenzo, Carotenuto, Antonio, and Lanzillo, Roberta

Abstract

Objective: People with multiple sclerosis (MS) might experience symptoms that are usually underestimated. Dysphagia should be evaluated within the Expanded Disability Status Scale (EDSS), but clinicians often do not assess it properly. The objectives of this study are as follows: To assess the prevalence of dysphagia in patients with MS utilizing the Swallowing Disturbance Questionnaire (SDQ); to examine the correlation with the EDSS; to investigate the relationship between dysphagia and clinico‐demographic characteristics of MS. Methods: In total, 177 MS patients underwent evaluations with EDSS, SDQ, cognitive functions, anxiety, depression, fatigue, and sleep quality tests. We compared clinico‐demographic data of patients with and without dysphagia and native‐EDSS to SDQ‐EDSS. Results: Out of the 177 MS patients, 56% of individuals were identified having dysphagia according to the SDQ with 41 patients exhibiting mild dysphagia, 31 showing moderate dysphagia and 27 patients having severe dysphagia. Only 6 patients had dysphagia recorded in the EDSS. SDQ‐EDSS scores were significantly higher than native scores. Dysphagia was associated with depressive symptoms and sleep quality. Interpretation: Dysphagia affects up to 56% of MS patients. The SDQ questionnaire is useful for identifying dysphagia, which can help in capturing disease progression and preventing complications like aspiration pneumonia. The SDQ‐EDSS was higher than the native‐EDSS, reflecting the poor ability of the native‐EDSS to evaluate certain symptoms such as dysphagia. The SDQ correlated with depressive symptoms, which are associated with a greater perception of MS symptoms, and poor sleep quality, which could be associated with the triggering of pathogenic mechanisms responsible for disease progression. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Disability assessment using Google Maps

Author

Lavorgna, Luigi, Iaffaldano, Pietro, Abbadessa, Gianmarco, Lanzillo, Roberta, Esposito, Sabrina, Ippolito, Domenico, Sparaco, Maddalena, Cepparulo, Simone, Lus, Giacomo, Viterbo, Rosa, Clerico, Marinella, Trojsi, Francesca, Ragonese, Paolo, Borriello, Giovanna, Signoriello, Elisabetta, Palladino, Raffaele, Moccia, Marcello, Brigo, Francesco, Troiano, Maria, Tedeschi, Gioacchino, and Bonavita, Simona

Published
2022
Full Text
View/download PDF

36. Cognitive trajectories in multiple sclerosis: a long-term follow-up study

Author

Carotenuto, Antonio, Costabile, Teresa, Pontillo, Giuseppe, Moccia, Moccia, Falco, Fabrizia, Petracca, Maria, Petruzzo, Martina, Russo, Cinzia Valeria, Di Stasi, Martina, Paolella, Chiara, Perillo, Teresa, Vola, Elena Augusta, Cipullo, Maria Brunella, Cocozza, Sirio, Lanzillo, Roberta, Brescia Morra, Vincenzo, and Saccà, Francesco

Published
2022
Full Text
View/download PDF

37. Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study

Author

Moccia, Marcello, primary, Affinito, Giuseppina, additional, Marrazzo, Giuseppina, additional, Ciarambino, Tiziana, additional, Di Procolo, Paolo, additional, Confalonieri, Licia, additional, Carotenuto, Antonio, additional, Petracca, Maria, additional, Lanzillo, Roberta, additional, Triassi, Maria, additional, Brescia Morra, Vincenzo, additional, and Palladino, Raffaele, additional

Published
2024
Full Text
View/download PDF

39. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

Author

De Mercanti, Stefania Federica, Signori, Alessio, Cordioli, Cinzia, Signoriello, Elisabetta, Lus, Giacomo, Bonavita, Simona, Abbadessa, Gianmarco, Lavorgna, Luigi, Maniscalco, Giorgia Teresa, Curti, Erica, Lorefice, Lorena, Cocco, Eleonora, Nociti, Viviana, Mirabella, Massimiliano, Baroncini, Damiano, Mataluni, Giorgia, Landi, Doriana, Petruzzo, Martina, Lanzillo, Roberta, Gandoglia, Ilaria, Laroni, Alice, Frangiamore, Rita, Sartori, Arianna, Cavalla, Paola, Costantini, Gianfranco, Capra, Ruggero, Sormani, Maria Pia, and Clerico, Marinella

Published
2021
Full Text
View/download PDF

40. Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans

Author

Hayashi, Genki, Jasoliya, Mittal, Sahdeo, Sunil, Saccà, Francesco, Pane, Chiara, Filla, Alessandro, Marsili, Angela, Puorro, Giorgia, Lanzillo, Roberta, Morra, Vincenzo Brescia, and Cortopassi, Gino

Subjects
Biochemistry and Cell Biology, Biological Sciences, Genetics, Clinical Research, Neurodegenerative, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Neurological, Animals, Humans, Mice, Cell Culture Techniques, Dimethyl Fumarate, Fibroblasts, Mitochondria, Multiple Sclerosis, Neuroprotective Agents, NF-E2-Related Factor 2, Organelle Biogenesis, Medical and Health Sciences, Genetics & Heredity
Abstract

The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitochondrial gene expression is more dependent on DMF's target Nrf2 than hydroxycarboxylic acid receptor 2 (HCAR2). Thus, DMF induces mitochondrial biogenesis primarily through its action on Nrf2, and is the first drug demonstrated to increase mitochondrial biogenesis with in vivo human dosing. This is the first demonstration that mitochondrial biogenesis is deficient in Multiple Sclerosis patients, which could have implications for MS pathophysiology and therapy. The observation that DMF stimulates mitochondrial biogenesis, gene expression and function suggests that it could be considered for mitochondrial disease therapy and/or therapy in muscle disease in which mitochondrial function is important.

Published
2017

42. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study

Author

Zanghì, Aurora, Gallo, Antonio, Avolio, Carlo, Capuano, Rocco, Lucchini, Matteo, Petracca, Maria, Bonavita, Simona, Lanzillo, Roberta, Ferraro, Diana, Curti, Erica, Buccafusca, Maria, Callari, Graziella, Barone, Stefania, Pontillo, Giuseppe, Abbadessa, Gianmarco, Di Francescantonio, Valeria, Signoriello, Elisabetta, Lus, Giacomo, Sola, Patrizia, Granella, Franco, Valentino, Paola, Mirabella, Massimiliano, Patti, Francesco, and D’Amico, Emanuele

Published
2021
Full Text
View/download PDF

43. Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study.

Author

Lapucci, Caterina, Frau, Jessica, Cocco, Eleonora, Coghe, Giancarlo, Petracca, Maria, Lanzillo, Roberta, Brescia Morra, Vincenzo, Nicoletti, Carolina Gabri, Landi, Doriana, Marfia, Girolama, Vercellino, Marco, Cavalla, Paola, Bianco, Assunta, Mirabella, Massimiliano, Torri Clerici, Valentina, Tomas, Eugenia, Ferrò, Maria Teresa, Grossi, Paola, Nozzolillo, Agostino, and Moiola, Lucia

Subjects
MAGNETIC resonance imaging, IMMUNOGLOBULIN M, THERAPEUTICS, MULTIPLE sclerosis, ALEMTUZUMAB
Abstract

Background: The reason why some multiple sclerosis (MS) patients show disease activity after alemtuzumab (ALM) is still unclear, but ocrelizumab (OCR) could represent an interesting sequential therapeutic approach. Objectives: To investigate safety and efficacy of OCR in MS patients with disease activity after two ALM courses. Methods: Observational retrospective multi-centers Italian cohort study. Results: Seventy-two subjects were included. Mean follow-up (FU) was 2.4 (±1) years. Forty-five patients (62.5%) experienced at least one adverse event (AE), with infections accounting for 96.7% of cases. A reduction in total lymphocytes was observed between OCR start and 6 months FU, driven by BCD19+ lymphocytes depletion (p < 0.001). Immunoglobulin M (IgM) levels decreased between OCR start and 6 months FU (p < 0.001). At 2-year FU, relapse, magnetic resonance imaging (MRI) activity and disability worsening-free survival were 92.1%, 90.8%, and 89.2%. The evidence of inflammatory activity between the two ALM courses was associated with higher risk of relapse, MRI activity, and NEDA-3 status loss in relapsing-remitting multiple sclerosis (RRMS; p = 0.02, p = 0.05, p = 0.01, respectively). Conclusions: OCR after two ALM courses seemed to be safe and effective. Early IgM hypogammaglobulinemia occurred in a high proportion of patients. The evidence of inflammatory activity between ALM courses seemed to increase the risk of MS re-activation on OCR treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

44. Radiological Reporting Systems in Multiple Sclerosis.

Author

Scaravilli, Alessandra, Tranfa, Mario, Pontillo, Giuseppe, Carotenuto, Antonio, Lapucci, Caterina, Nistri, Riccardo, Signoriello, Elisabetta, Moccia, Marcello, Tortorella, Carla, Capra, Ruggero, Lus, Giacomo, Inglese, Matilde, Gasperini, Claudio, Lanzillo, Roberta, Pozzilli, Carlo, Brescia Morra, Vincenzo, Brunetti, Arturo, Petracca, Maria, and Cocozza, Sirio

Subjects
MULTIPLE sclerosis, CEREBRAL atrophy, MEDICAL software, DIAGNOSTIC imaging, NEUROLOGISTS, PICTURE archiving & communication systems
Abstract

(1) Background: Although MRI is a well-established tool in Multiple Sclerosis (MS) diagnosis and management, neuroradiological reports often lack standardization and/or quantitative information, with possible consequences in clinical care. The aim of this study was to evaluate the impact of information provided by neuroradiological reports and different reporting systems on the clinical management of MS patients. (2) Methods: An online questionnaire was proposed to neurologists working in Italian tertiary care level MS centers. Questions assessed the impact of different MRI-derived biomarkers on clinical choices, the preferred way of receiving radiological information, and the neurologists' opinions about different reporting systems and the use of automated software in clinical practice. (3) Results: The online survey was completed by 62 neurologists. New/enlarging (100%) lesions, the global T2w/FLAIR lesion load (96.8%), and contrast-enhancing (95.2%) lesions were considered the most important biomarkers for therapeutic decision, while new/enlarging lesions (98.4%), global T2w/FLAIR lesion load (96.8%), and cerebral atrophy (90.3%) were relevant to prognostic evaluations. Almost all participants (98.4%) considered software for medical imaging quantification helpful in clinical management, mostly in relation to prognostic evaluations. (4) Conclusions: These data highlight the impact of providing accurate and reliable data in neuroradiological reports. The use of software for medical imaging quantification in MS can be helpful to standardize radiological reports and to provide useful clinical information to neurologists. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study

Author

Russo, Camilla, Cocozza, Sirio, Riccio, Eleonora, Pontillo, Giuseppe, Petruzzelli, Luigi Annicchiarico, Lanzillo, Roberta, Spinelli, Letizia, Colomba, Paolo, Duro, Giovanni, Imbriaco, Massimo, Russo, Cinzia Valeria, De Riso, Giulia, Di Risi, Teodolinda, Tedeschi, Enrico, Cuocolo, Alberto, Brunetti, Arturo, Morra, Vincenzo Brescia, Cocozza, Sergio, and Pisani, Antonio

Published
2020
Full Text
View/download PDF

46. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

Author

Ferraro, Diana, Annovazzi, Pietro, Moccia, Marcello, Lanzillo, Roberta, De Luca, Giovanna, Nociti, Viviana, Fantozzi, Roberta, Paolicelli, Damiano, Ragonese, Paolo, Gajofatto, Alberto, Boffa, Laura, Cavalla, Paola, Lo Fermo, Salvatore, Buscarinu, Maria Chiara, Lorefice, Lorena, Cordioli, Cinzia, Calabrese, Massimiliano, Gallo, Antonio, Pinardi, Federica, Tortorella, Carla, Di Filippo, Massimiliano, Camera, Valentina, Maniscalco, Giorgia Teresa, Radaelli, Marta, Buttari, Fabio, Tomassini, Valentina, Cocco, Eleonora, Gasperini, Claudio, and Solaro, Claudio

Published
2020
Full Text
View/download PDF

47. Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

Author

Buonomo, Antonio Riccardo, Viceconte, Giulio, Calabrese, Massimiliano, De Luca, Giovanna, Tomassini, Valentina, Cavalla, Paola, Maniscalco, Giorgia Teresa, Ferraro, Diana, Nociti, Viviana, Radaelli, Marta, Buscarinu, Maria Chiara, Paolicelli, Damiano, Gajofatto, Alberto, Annovazzi, Pietro, Pinardi, Federica, Di Filippo, Massimiliano, Cordioli, Cinzia, Zappulo, Emanuela, Scotto, Riccardo, Gentile, Ivan, Spiezia, Antonio Luca, Petruzzo, Martina, De Angelis, Marcello, Morra, Vincenzo Brescia, Solaro, Claudio, Gasperini, Claudio, Cocco, Eleonora, Moccia, Marcello, and Lanzillo, Roberta

Published
2022
Full Text
View/download PDF

49. 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis

Author

Pontillo, Giuseppe, Cocozza, Sirio, Di Stasi, Martina, Carotenuto, Antonio, Paolella, Chiara, Cipullo, Maria Brunella, Perillo, Teresa, Vola, Elena Augusta, Russo, Camilla, Masullo, Marco, Moccia, Marcello, Lanzillo, Roberta, Tedeschi, Enrico, Elefante, Andrea, Brescia Morra, Vincenzo, Brunetti, Arturo, Quarantelli, Mario, and Petracca, Maria

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results